Discontinued — last reported Q3 '25
D&A
Stryker D&A increased by 10.1% to $120.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.1%, from $109.00M to $120.00M. Over 3 years (FY 2021 to FY 2024), D&A shows relatively stable performance with a 0.2% CAGR.
Analysis
How to read this metric
Higher levels indicate significant capital investment in infrastructure or acquisitions, while lower levels may suggest aging assets or limited capital expenditure.
Detailed definition
This represents the non-cash expense allocated to the cost of tangible and intangible assets over their useful lives. Be...
Peer comparison
High in capital-intensive industries like manufacturing and healthcare devices; lower in service-based sectors.
depreciation_and_amortization_cfHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.00M | $144.00M | $145.00M | $150.00M | $160.00M | $159.00M | $158.00M | $96.00M | $98.00M | $98.00M | $343.00M | $107.00M | $103.00M | $109.00M | $304.00M | $105.00M | $109.00M | $120.00M |
| QoQ Change | — | -3.4% | +0.7% | +3.4% | +6.7% | -0.6% | -0.6% | -39.2% | +2.1% | +0.0% | +250.0% | -68.8% | -3.7% | +5.8% | +178.9% | -65.5% | +3.8% | +10.1% |
| YoY Change | — | — | — | — | +7.4% | +10.4% | +9.0% | -36.0% | -38.8% | -38.4% | +117.1% | +11.5% | +5.1% | +11.2% | -11.4% | -1.9% | +5.8% | +10.1% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| MedSurg and Neurotechnology: | $56.00M | $60.00M | $38.00M | $48.00M | $58.00M | $56.00M | $66.00M | $55.00M |
| Orthopaedics | — | — | — | $107.00M | — | — | — | — |
| Total | $103.00M | $109.00M | $304.00M | $105.00M | $109.00M | $120.00M | — | — |
Orthopaedics and Spine is derived from annual filings.
Orthopaedics and Spine was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
D&A at Other Companies
Frequently Asked Questions
- What is Stryker's d&a?
- Stryker (SYK) reported d&a of $120.00M in Q3 2025.
- How has Stryker's d&a changed year-over-year?
- Stryker's d&a increased by 10.1% year-over-year, from $109.00M to $120.00M.
- What is the long-term trend for Stryker's d&a?
- Over 3 years (2021 to 2024), Stryker's d&a has grown at a 0.2% compound annual growth rate (CAGR), from $619.00M to $623.00M.
- What does d&a mean?
- The non-cash accounting expense for the wear and tear or expiration of assets.